Evidence map›Paper›PMID 42291613›Full record

ArticleScientific African2026

Burden of veno-occlusive disease in tigray region of ethiopia: Evidence from community-based survey.

Mekonnen Haileselassie, Hagos Degefa Hidru, Yimer Mulugeta Agga, Mulugeta Woldu Abrha, Brhane Ayele, Hailay Gebretnsae, Ataklti Gebretsadik, Hayelom Kahsay, Tsegay Hadgu, Nega Mamo and 17 more

Abstract read
In one paragraph

Article in Scientific African, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Mekonnen HaileselassieTigray Health Research Institute, Tigray, Ethiopia.
Hagos Degefa HidruTigray Health Research Institute, Tigray, Ethiopia.
Yimer Mulugeta AggaEthiopian Public Health Institute, Ethiopia.
Mulugeta Woldu AbrhaTigray Health Research Institute, Tigray, Ethiopia.
Brhane AyeleTigray Health Research Institute, Tigray, Ethiopia.
Hailay GebretnsaeTigray Health Research Institute, Tigray, Ethiopia.
Ataklti GebretsadikTigray Health Research Institute, Tigray, Ethiopia.
Hayelom KahsayTigray Health Research Institute, Tigray, Ethiopia.
Tsegay HadguTigray Health Research Institute, Tigray, Ethiopia.
Nega MamoTigray Health Research Institute, Tigray, Ethiopia.
Fisseha AshebrTigray Health Research Institute, Tigray, Ethiopia.
Mebrahtom Hafte AmehaTigray Regional Health Bureau, Tigray, Ethiopia.
Amanuel HaileTigray Regional Health Bureau, Tigray, Ethiopia.
Tesfay Belay RedaTigray Agriculture Research Institute, Tigray, Ethiopia.
Alem RedaTigray Agriculture Research Institute, Tigray, Ethiopia.
Daniel WoldemichaelTigray Agriculture Research Institute, Tigray, Ethiopia.
Feyisa RegessaEthiopian Public Health Institute, Ethiopia.
Geremew TasewEthiopian Public Health Institute, Ethiopia.
Getachew TolleraEthiopian Public Health Institute, Ethiopia.
Mesay HailuEthiopian Public Health Institute, Ethiopia.
Abrha TesfayMekelle University, College of Veterinary Medicine, Tigray, Ethiopia.
Samuel Aregay GebreslassieWorld Health Organization, Ethiopia.
Abiy Girmay HaddisWorld Health Organization, Ethiopia.
Senait Tekeste FekaduWorld Health Organization, Ethiopia.
Patrick Okumu AbokWorld Health Organization, Ethiopia.
Mussie AlemayehuMekelle University, College of Health Sciences, School of Public Health, Ethiopia.
Afework MulugetaMekelle University, College of Health Sciences, School of Public Health, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatic veno-occlusive disease refers to a toxic liver injury leading to obstruction and significant morbidity and mortality. Pyrrolizidine alkaloids are among the commonest causes of toxins. In the Tigray region of Ethiopia, this disease linked to toxic plant Ageratum conyzoides. Disruption interventions caused by the COVID-19 pandemic and the Tigray war, potentially leading to escalated reports of the disease. Therefore, this study aims to assess the burden and distribution of hepatic veno-occlusive disease in the northwestern zone of the Tigray region of Ethiopia. Methods: A community-based cross-sectional study was conduct from January to February 2025, involving 2845 households and study participants were selected using multistage random sampling techniques. The data was collected from a defined population within a specific community at a point in time using Open Data Kit tool and exported to SPSS version 25.0 for cleaning and analysis. Multivariable logistic regression was used to identify the association of factors with hepatic veno-occlusive disease. Statistical significance was reported using adjusted odds ratio along with a 95% confidence interval, and at p-value of <0.05. Result: Overall, 6.9% (95% CI: 6.0, 7.9) of households were affected, with 180 cases per 10,000 population. About 250 cumulative deaths per 10,000 population and a notable cumulative case fatality rate (CFR) of 58.1% were found since 2002. This showed with considerable differences among the various administrative districts in the zone. The risk was significantly increased among age groups above thirty, having a larger family size, and believing supernatural force was a cause for the disease. Conclusion: Unevenly distributed, high morbidity, mortality, and case fatality rate due to hepatic veno-occlusive disease were found in Tigray region.

Indexed as

Ageratum conyzoidesBurdenHepatic veno-occlusive diseaseNorthwestern zoneTigray

Identifiers

PMID42291613
PMCPMC13263310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.